Author: Shuya Lu; Qi Zhou; Liping Huang; Qianling Shi; Siya Zhao; Zijun Wang; Weiguo Li; Yuyi Tang; Yanfang Ma; Xufei Luo; Toshio Fukuoka; Hyeong Sik Ahn; Myeong Soo Lee; Zhengxiu Luo; Enmei Liu; Yaolong Chen; Chenyan Zhou; Donghong Peng
Title: Effectiveness and Safety of Glucocorticoids to Treat COVID-19: A Rapid Review and Meta-Analysis Document date: 2020_4_22
ID: 935r7w01_12
Snippet: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org /10.1101 /10. /2020 randomized controlled trials (RCTs) and cohort studies comparing glucocorticoid therapy versus placebo or comparing a combination of glucocorticoids and symptomatic treatment with symptomatic treatment alone. The primary outcome of interest was mortality, and secondary outcomes included duration of lung inflammation absorption, durati.....
Document: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org /10.1101 /10. /2020 randomized controlled trials (RCTs) and cohort studies comparing glucocorticoid therapy versus placebo or comparing a combination of glucocorticoids and symptomatic treatment with symptomatic treatment alone. The primary outcome of interest was mortality, and secondary outcomes included duration of lung inflammation absorption, duration of hospital stay, duration of fever, and other adverse effects like coinfections (bacterial or fungal infections), kaliopenia, and osteonecrosis of femoral head (ONFH).
Search related documents:
Co phrase search for related documents- adverse effect and control trial: 1, 2, 3, 4, 5
- adverse effect and femoral head: 1
- adverse effect and glucocorticoid therapy: 1, 2
- adverse effect and hospital stay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- adverse effect and hospital stay duration: 1, 2
- adverse effect and lung inflammation: 1
- adverse effect and ONFH femoral head: 1
- adverse effect and ONFH femoral head osteonecrosis: 1
- adverse effect and primary outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- adverse effect and secondary outcome: 1, 2, 3, 4, 5
- cohort study and control trial: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- cohort study and femoral head: 1, 2
- cohort study and fever duration: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- cohort study and fungal bacterial infection: 1, 2
- cohort study and glucocorticoid therapy: 1, 2, 3
- cohort study and hospital stay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- cohort study and hospital stay duration: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51
- cohort study and interest primary outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- cohort study and lung inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
Co phrase search for related documents, hyperlinks ordered by date